Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sotirios P Fortis

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Cancers|June 24, 2020
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate CancerSavvas Stokidis, Sotirios P Fortis, Paraskevi Kogionou, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Neonatal Sepsis-Induced Coagulopathy in the Light of Developmental Hemostasis: Friend or Foe?Paraskevi Papadogeorgou, Rozeta Sokou, Sotirios P Fortis, et al.
International Journal of Molecular Sciences|February 13, 2025
Morphogens and Cell-Derived Structures (Exosomes and Cytonemes) as Components of the Communication Between CellsStavros Chideriotis, Alkmini T Anastasiadi, Vassilis L Tzounakas, et al.
International Journal of Molecular Sciences|July 28, 2022
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAsArsinoe C Thomaidou, Panagiota Batsaki, Maria Adamaki, et al.
International Journal of Molecular Sciences|March 29, 2023
Frequencies of an Immunogenic HER-2/<i>neu</i> Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate CancerMaria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou, et al.
Cancer Immunology, Immunotherapy : CII|September 6, 2017
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical modelSotirios P Fortis, Louisa G Mahaira, Eleftheria A Anastasopoulou, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck CancerMichael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, et al.
Anticancer Research|December 25, 2016
Potential Prognostic Molecular Signatures in a Preclinical Model of MelanomaSotirios P Fortis, Eleftheria A Anastasopoulou, Ioannis F Voutsas, et al.
Oncology Letters|September 18, 2025
Novel biomarkers for prognosis in patients with localized prostate cancerMaria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou, et al.
Cancers|July 29, 2023
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate CancerSotirios P Fortis, Panagiota Batsaki, Savvas Stokidis, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Cancers|June 24, 2020
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate CancerSavvas Stokidis, Sotirios P Fortis, Paraskevi Kogionou, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Neonatal Sepsis-Induced Coagulopathy in the Light of Developmental Hemostasis: Friend or Foe?Paraskevi Papadogeorgou, Rozeta Sokou, Sotirios P Fortis, et al.
International Journal of Molecular Sciences|February 13, 2025
Morphogens and Cell-Derived Structures (Exosomes and Cytonemes) as Components of the Communication Between CellsStavros Chideriotis, Alkmini T Anastasiadi, Vassilis L Tzounakas, et al.
International Journal of Molecular Sciences|July 28, 2022
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAsArsinoe C Thomaidou, Panagiota Batsaki, Maria Adamaki, et al.
International Journal of Molecular Sciences|March 29, 2023
Frequencies of an Immunogenic HER-2/<i>neu</i> Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate CancerMaria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou, et al.
Cancer Immunology, Immunotherapy : CII|September 6, 2017
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical modelSotirios P Fortis, Louisa G Mahaira, Eleftheria A Anastasopoulou, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck CancerMichael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, et al.
Anticancer Research|December 25, 2016
Potential Prognostic Molecular Signatures in a Preclinical Model of MelanomaSotirios P Fortis, Eleftheria A Anastasopoulou, Ioannis F Voutsas, et al.
Oncology Letters|September 18, 2025
Novel biomarkers for prognosis in patients with localized prostate cancerMaria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou, et al.
Cancers|July 29, 2023
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate CancerSotirios P Fortis, Panagiota Batsaki, Savvas Stokidis, et al.
Pageof 7